Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High‐Dosage L. reuteri in H. pylori ‐Infected Adults

Documenti analoghi

• Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, Italy
  di: Maria Pina Dore, et al.
  Pubblicazione: (2024)
• Self‐Correcting Method for Highly Effective Office‐Based Helicobacter pylori Therapy Using Cumulative Test of Cure Data
  di: Maria Pina Dore, et al.
  Pubblicazione: (2024)
• Comparative Efficacy and Safety of Potassium‐Competitive Acid Blockers and Proton Pump Inhibitors for First‐Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta‐Analysis
  di: Mengling Ouyang, et al.
  Pubblicazione: (2024)
• Reevaluating the Adverse Events With the Same‐Dosage Regimen in Hemodialysis Patients Undergoing Helicobacter pylori Eradication
  di: Keigo Misawa, et al.
  Pubblicazione: (2025)
• Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric Microbiome
  di: Camilia Metadea Aji Savitri, et al.
  Pubblicazione: (2025)